[go: up one dir, main page]

IL133908A0 - Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) - Google Patents

Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)

Info

Publication number
IL133908A0
IL133908A0 IL13390898A IL13390898A IL133908A0 IL 133908 A0 IL133908 A0 IL 133908A0 IL 13390898 A IL13390898 A IL 13390898A IL 13390898 A IL13390898 A IL 13390898A IL 133908 A0 IL133908 A0 IL 133908A0
Authority
IL
Israel
Prior art keywords
ssri
prevention
treatment
selective serotonin
uptake inhibitors
Prior art date
Application number
IL13390898A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL133908A0 publication Critical patent/IL133908A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13390898A 1997-07-14 1998-07-14 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) IL133908A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714841.5A GB9714841D0 (en) 1997-07-14 1997-07-14 Treatment method
PCT/GB1998/002073 WO1999003469A1 (en) 1997-07-14 1998-07-14 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)

Publications (1)

Publication Number Publication Date
IL133908A0 true IL133908A0 (en) 2001-04-30

Family

ID=10815849

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13390898A IL133908A0 (en) 1997-07-14 1998-07-14 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)

Country Status (16)

Country Link
US (1) US6372763B1 (xx)
EP (1) EP0996445A1 (xx)
JP (1) JP2001510155A (xx)
KR (1) KR20010021796A (xx)
CN (1) CN1263465A (xx)
AU (1) AU739466B2 (xx)
BR (1) BR9811004A (xx)
CA (1) CA2296468A1 (xx)
GB (1) GB9714841D0 (xx)
HU (1) HUP0002643A3 (xx)
IL (1) IL133908A0 (xx)
NO (1) NO20000169L (xx)
NZ (1) NZ502201A (xx)
PL (1) PL337996A1 (xx)
TR (1) TR200000090T2 (xx)
WO (1) WO1999003469A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
WO2003011278A1 (en) 2001-07-31 2003-02-13 H. Lundbeck A/S Crystalline composition containing escitalopram
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2004058354A1 (en) * 2002-12-20 2004-07-15 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive event

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192217T3 (es) * 1995-07-17 2003-10-01 Pfizer Sertralina para el tratamiento de pacientes tras un infarto de miocardio.

Also Published As

Publication number Publication date
NO20000169D0 (no) 2000-01-13
AU8349498A (en) 1999-02-10
JP2001510155A (ja) 2001-07-31
AU739466B2 (en) 2001-10-11
CA2296468A1 (en) 1999-01-28
KR20010021796A (ko) 2001-03-15
NZ502201A (en) 2001-12-21
EP0996445A1 (en) 2000-05-03
US6372763B1 (en) 2002-04-16
HUP0002643A3 (en) 2001-11-28
TR200000090T2 (tr) 2000-09-21
CN1263465A (zh) 2000-08-16
WO1999003469A1 (en) 1999-01-28
GB9714841D0 (en) 1997-09-17
NO20000169L (no) 2000-01-13
HUP0002643A2 (hu) 2001-10-28
PL337996A1 (en) 2000-09-25
BR9811004A (pt) 2000-09-19

Similar Documents

Publication Publication Date Title
HUP0200495A3 (en) Method of treating eating disorders
PL320952A1 (en) Cycloalkanon pyridines, method of obtaining and therapeutic agents containing them
IL139591A0 (en) Combination therapy for treatment of bipolar disorders
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
PL320822A1 (en) Sulphonamidic compounds as therapeutic agents for treatment of central nervous system, method of obtaining novel sulphonamidic compounds and drugs containing such compounds
AU2209697A (en) Fluorocarbons for diagnosis and treatment of articular disorders
PL317930A1 (en) Oxalydine compounds, method of obtaining them and therapeutic agents
IL126592A0 (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders
HUP0400914A3 (en) Methods of treatment of mitochondrial disorders
PL339449A1 (en) Treatment of bone fractures involving the use of pthrp analogues
HUP0004025A3 (en) Treatment of conduct disorder using norepinephrine reuptake inhibitors
HU0001471D0 (en) New method of treatment
HU9803018D0 (en) Methods and compositions for the treatment and prevention of tumors, tumor-veloted disorders and cachexia
AU2003297356A8 (en) Prevention and treatment of cardiac arrhythmias
MXPA02001790A (es) Composiciones que incluyen el modafinil, para el tratamiento de desordenes en la alimentacion y para estimular el apetito.
AU2002357830A8 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
PL312079A1 (en) Derivatives of 3-phenyl isoquinolin-1 (2h)-one, method of obtaining them, therapeutic agent and pharmaceutical composition
NO995231D0 (no) Terapeutisk behandling av hudlidelser
IL133908A0 (en) Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)
AU2003296724A8 (en) Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
WO1999057133A3 (en) Inhibitors of nf-kb activation
SI0888114T1 (en) Use of (+)-alpha-(2,3-dimethoxyphenyl)-1- 2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
AU7106300A (en) Treatment of skin disorders
HUP0201966A3 (en) Methods of treatment and drug screening methods
EP1161451A4 (en) HUMAN ALPHA ENDOKIN AND METHOD FOR ITS USE